tianjin chase sun pharm-a
(300026:Shenzhen)

Last CNY32.60 CNY

Change Today -0.04 / -0.12%

Volume 2.5M

300026 On Other Exchanges

Symbol

Exchange

300026:CH

Shenzhen

As of 3:00 AM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

tianjin chase sun pharm-a (300026) Snapshot

Open CNY32.76		Previous Close CNY32.64
Day High CNY32.80		Day Low CNY31.91
52 Week High 05/16/13 - CNY34.10		52 Week Low 05/21/12 - CNY13.17
Market Cap 12.2B		Average Volume 10 Days 2.5M
EPS TTM CNY0.72		Shares Outstanding 374.0M
EX-Date 05/7/13		P/E TM 45.3x
Dividend CNY0.07		Dividend Yield 0.20%

Current Stock Chart for TIANJIN CHASE SUN PHARM-A (300026)

300026:CH Historical Stock Quote
300026:CH Advanced Stock Chart

Related News

No related news articles were found.

tianjin chase sun pharm-a (300026) Related Businessweek News

No Related Businessweek News Found

tianjin chase sun pharm-a (300026) Details

Tianjin Chase Sun Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals. The company offers prescription pharmaceutical products, including Chinese medicines, nervous system drugs, blood system drugs, circulatory system drugs, antimicrobial drugs, vitamin drugs, anti-tumor drugs, and others. Its drug products comprise Xuebijing injection, fasudil hydrochloride injection, low molecular weight heparin calcium injection, Simvastatin capsules, Cetirizine hydrochloride capsules, clarithromycin granules, and piracetam injection. The company also provides research, development, and consulting services for bioengineering drugs, genetic engineering drugs, and plant drugs, as well as offers freight services. Tianjin Chase Sun Pharmaceutical Co., Ltd. is based in Tianjin, China.

Detailed 300026:CH Company Description...

www.chasesun.cn

tianjin chase sun pharm-a (300026) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tianjin chase sun pharm-a (300026) Key Developments

Tianjin Chase Sun Pharmaceutical Co., Ltd. to Report Q1, 2013 Results on Apr 25, 2013

Apr 25 13

Tianjin Chase Sun Pharmaceutical Co., Ltd. announced that they will report Q1, 2013 results on Apr 25, 2013

Tianjin Chase Sun Pharmaceutical Co., Ltd. Proposes Cash Dividend for 2012, Proposes Amendments to the Articles of Association

Mar 26 13

Tianjin Chase Sun Pharmaceutical Co., Ltd. proposed the cash dividend (tax included) of CNY 1.00000000 per 10 shares for 2012, at the annual general meeting to be held on April 16, 2013. The company also proposed amendments to the articles of association, at the annual general meeting to be held on April 16, 2013.

Tianjin Chase Sun Pharmaceutical Co., Ltd., Annual General Meeting, Apr 16, 2013

Mar 26 13

Tianjin Chase Sun Pharmaceutical Co., Ltd., Annual General Meeting, Apr 16, 2013., at 10:00 China Standard Time. Agenda: To consider 2012 work report of the board of directors; to consider 2012 work report of the supervisory committee; to consider 2012 annual report and its summary; to consider 2012 financial resolution report; to consider 2012 profit distribution plan; to consider amendments to the company's articles of association; to consider re-election of director; to consider elect directors; to consider remuneration for directors; to consider re-election of supervisors, accumulative voting system applicable; to consider election of supervisor candidate; to consider remuneration for supervisors; and to consider reappointment of 2013 audit firm.